Levemir

Type: Product
Name: Levemir
First reported Sep 17 2014 - Updated 13 hours ago - 4 reports

Tresiba Insulin Improves Glycemic Control in Children with Type 1 Diabetes

Krystle VermesPublished Online: Thursday, September 18, 2014Follow Pharmacy_Times:Combined with bolus insulin aspart (NovoLog), insulin degludec (Tresiba) improves long-term glycemic control in children and adolescents with type 1 diabetes, according ... [Published Pharmacy Times - 13 hours ago]
Entities: Tresiba, Insulin, Levemir
First reported 15 hours ago - Updated 15 hours ago - 1 reports

Human Microbiome Market worth $658 Million by 2023 - New Report by MarketsandMarkets

PRWebThe "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) -Global Forecast to ... [Published CW 50 Detroit - 15 hours ago]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Psychology of Diabetes and Eating

Diabetes is not a simple disease. It is an all-consuming disease as it affects hormones, emotional and mental wellbeing, and ticks in the back of the mind twenty-four hours per day. Maybe that's just in my case, but I think I'm not alone in feeling this ... [Published Diabetes Health Magazine - Sep 17 2014]
First reported Sep 11 2014 - Updated Sep 12 2014 - 1 reports

Lilly and Boehringer diabetes biosimilar sees EU approval

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC).The copycat version of Sanofi’s best-selling insulin makes it the fourth diabetes product approved in the EU under a Lilly-Boehringer ... [Published Pharmafocus - Sep 11 2014]
First reported Sep 10 2014 - Updated Sep 11 2014 - 1 reports

Lilly, Boehringer copy of Sanofi's insulin gets EU approval

Sept 10 (Reuters) - Eli Lilly and Co and Boehringer Ingelheim said on Wednesday that the European Commission approved their copycat version of Sanofi SA's blockbuster insulin, Lantus. The treatment, to be manufactured by Lilly, comprises a type of basal ... [Published Sharenet - Sep 10 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Lilly basal bests Lantus in T1D, despite safety concerns

Share this article: Eli Lilly may not need to pin its hopes on Basaglar, the generic version of Sanofi's Lantus which is now in marketing limbo, after all. The Indianapolis drugmaker unveiled new data today that shows its basal insulin peglispro significantly ... [Published Medical Marketing And Media - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 1 reports

Novo Nordisk to focus research efforts on diabetes

The largest manufacturer of insulin, Novo Nordisk, has stated its intention to focus on its core business of developing diabetes treatments.The Danish company had been working on a treatment for rheumatoid arthritis, an autoimmune disease that causes ... [Published Diabetes.co.uk - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Novo Nordisk debuts diabetes combo in Mexico

Danish pharma company Novo Nordisk has not had the best of times with its diabetes pipeline of late, but chalked up a success with the first launch of its Ryzodeg combination insulin product in Mexico.Ryzodeg combines the long-acting basal insulin in ... [Published PMLive - Sep 02 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

FDA Gives “Tentative Approval” to BI/Lilly’s insulin glargine Basaglar – Full Approval Pending Lawsuit with Sanofi

Twitter summary: FDA grants “tentative approval” to Lilly/BI’s Basaglar – new insulin option will be an alternative to Lantus in futureOn August 18, Eli Lilly and Boehringer Ingelheim (BI) announced that the FDA granted “tentative approval” to Basaglar ... [Published diaTribe - Aug 29 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Human medicines European public assessment report (EPAR): Levemir, insulin detemir, Revision: 19, Authorised

Entities: Levemir, Humanism
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Type 2

Found myself in ketoacidosis after being off Orals at least 1mo. Took 40u Novolog, 120u Levemir-it was available. My blood glucose is 534, extremely restless, urinating every hour, sickening sweet smell all around me, tried bathing. Plan to recheck ... [Published HealthBoards - Jul 10 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Novo Nordisk Announces U.S. Launch of New Insulin Device Levemir® FlexTouch®

PLAINSBORO, N.J., June 19, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir® FlexTouch® (insulin detemir [rDNA origin] injection) in the United ... [Published PR Newswire: Policy & Public Interest - Jun 19 2014]

Quotes

"When treating children and adolescents with type 1 diabetes, it is critical that the right balance between glycemic control and side effecteffect management is maintained to ensure the best possible long-term outcomes,” noted Nandu Thalange, MD, a pediatric endocrinologist at Norfolk and Norwich University Hospital in the United Kingdom. “These data show that Tresiba has the potential to offer youngsters with diabetes a new treatment option, which may help them achieve better control of their diabetes.”"
The "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) -Global Forecast to 2023" , provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the human...
"These data show that Tresiba has the potential to offer youngsters with diabetes a new treatment option, which may help them achieve better control of their diabetes" said Dr. Nandu Thalange of Norfolk and Norwich University Hospital in Britain, one of the study's lead investigators
"The marketing authorisation for this insulin glargine product in Europe is a significant achievement for the Lilly-Boehringer Ingelheim Alliance,” says Enrique Conterno, president at Lilly Diabetes."

More Content

All (34) | News (20) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
Tresiba Insulin Improves Glycemic Control in Ch... [Published Pharmacy Times - 13 hours ago]
Human Microbiome Market worth $658 Million by 2... [Published CW 50 Detroit - 15 hours ago]
Novo Nordisk's Tresiba Effective in Children & ... [Published Zacks.com - Sep 17 2014]
Insulin Degludec (Tresiba) Demonstrates Long-Te... [Published PT Community - Sep 17 2014]
Novo's New Diabetes Drug Effective and Safe for... [Published American Journal of Public Health - Sep 17 2014]
Sanofi Still Ahead Of Novo Nordisk In Insulin D... [Published Bidness Etc - Sep 17 2014]
Psychology of Diabetes and Eating [Published Diabetes Health Magazine - Sep 17 2014]
Lilly and Boehringer diabetes biosimilar sees E... [Published Pharmafocus - Sep 11 2014]
Human Microbiome Market Worth $658 Million by 2023 [Published Reliance Trust - Sep 10 2014]
Lilly, Boehringer copy of Sanofi's insulin gets... [Published Sharenet - Sep 10 2014]
Lilly basal bests Lantus in T1D, despite safety... [Published Medical Marketing And Media - Sep 05 2014]
Novo Nordisk Discontinues Inflammatory Disease ... [Published Bioresearch Online - Sep 04 2014]
Novo Nordisk to focus research efforts on diabetes [Published Diabetes.co.uk - Sep 03 2014]
Novo Nordisk debuts diabetes combo in Mexico [Published PMLive - Sep 02 2014]
FDA Gives “Tentative Approval” to BI/Lilly’s in... [Published diaTribe - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 22 2014]
Biological Drugs Market Will Reach USD 2, 87,13... [Published PR.com Press Releases - Aug 19 2014]
Biological Drugs Market - Global Industry Analy... [Published TickerTech.com - Aug 12 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Aug 05 2014]
Biological Drugs Market: Global Industry Analys... [Published PRWeb - Jul 25 2014]
Human Insulin Market Worth $42 Billion by 2019 ... [Published PRWeb - Jul 22 2014]
Type 2 [Published HealthBoards - Jul 10 2014]
Worldwide Human Insulin Market 2014-2018 Resear... [Published PRWeb - Jun 30 2014]
Human Insulin Market worth $42 Billion by 2018 [Published PR Newswire: General Business - Jun 27 2014]
Novo Nordisk Announces U.S. Launch of New Insul... [Published PR Newswire: Policy & Public Interest - Jun 19 2014]
FDA to Pharma: Forget About Tweets! But You Can... [Published Pharma Marketing Blog - Jun 18 2014]
Pharma: Your Brand Celebrity Spokespersons Are ... [Published Pharma Marketing Blog - May 29 2014]
Obamacare Cannot Reduce the Cost of Modern Medi... [Published RedState Blog - May 03 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 22 2014]
Biological Drugs Market Will Reach USD 2, 87,13... [Published PR.com Press Releases - Aug 19 2014]
New York, NY, August 19, 2014 --( PR.com )-- Persistence Market Research (http://www.persistencemarketresearch.com) Released New Market Report on "Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020” the global biological ...
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Aug 05 2014]
Type 2 [Published HealthBoards - Jul 10 2014]
Found myself in ketoacidosis after being off Orals at least 1mo. Took 40u Novolog, 120u Levemir-it was available. My blood glucose is 534, extremely restless, urinating every hour, sickening sweet smell all around me, tried bathing. Plan to recheck ...
Human Insulin Market worth $42 Billion by 2018 [Published PR Newswire: General Business - Jun 27 2014]
DALLAS, June 27, 2014 /PRNewswire/ --According to the new market research report, "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand ...
1 2

Press Releases

sort by: Date | Relevance
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - May 01 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - May 01 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.